Pharma & Healthcare
Global Loratadine Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 04, 25
- ID: 569139
- Pages: 190
- Figures: 193
- Views: 6
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Loratadine Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Heilongjiang Nuojie Pharmaceutical Co., Ltd.
Sancai Shiqi Pharmaceutical Co., Ltd.
Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
Sichuan Deyuan Pharmaceutical Group Co., Ltd.
Jilin Jinheng Pharmaceutical Co., Ltd.
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Hubei Minkang Pharmaceutical Co., Ltd.
Anhui Guosen Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Hunan Zhongnan Pharmaceutical Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
Tonghua Great Wall Pharmaceutical Co., Ltd.
Yunnan Longfa Pharmaceutical Co., Ltd.
Shanxi Xinyu Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Sichuan Shenghe Pharmaceutical Co., Ltd.
Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
Hunan Erkang Pharmaceutical Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
Segment by Type
20 mg/Tablet
40 mg/Tablet
60 mg/Tablet
Segment by Application
Hospital
Pharmacy
Online e-commerce
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Loratadine Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Loratadine Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Heilongjiang Nuojie Pharmaceutical Co., Ltd.
Sancai Shiqi Pharmaceutical Co., Ltd.
Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
Sichuan Deyuan Pharmaceutical Group Co., Ltd.
Jilin Jinheng Pharmaceutical Co., Ltd.
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Hubei Minkang Pharmaceutical Co., Ltd.
Anhui Guosen Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Hunan Zhongnan Pharmaceutical Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
Tonghua Great Wall Pharmaceutical Co., Ltd.
Yunnan Longfa Pharmaceutical Co., Ltd.
Shanxi Xinyu Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Sichuan Shenghe Pharmaceutical Co., Ltd.
Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
Hunan Erkang Pharmaceutical Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
Segment by Type
20 mg/Tablet
40 mg/Tablet
60 mg/Tablet
Segment by Application
Hospital
Pharmacy
Online e-commerce
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Loratadine Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Loratadine Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Loratadine Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 20 mg/Tablet
1.2.3 40 mg/Tablet
1.2.4 60 mg/Tablet
1.3 Market Segmentation by Application
1.3.1 Global Loratadine Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Online e-commerce
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Loratadine Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Loratadine Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Loratadine Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Loratadine Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Loratadine Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Loratadine Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 20 mg/Tablet Market Size by Manufacturers
3.5.2 40 mg/Tablet Market Size by Manufacturers
3.5.3 60 mg/Tablet Market Size by Manufacturers
3.6 Global Loratadine Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Loratadine Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Loratadine Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Loratadine Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Loratadine Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Loratadine Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Loratadine Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Loratadine Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Loratadine Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Loratadine Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Loratadine Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Loratadine Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Loratadine Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Loratadine Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Loratadine Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Loratadine Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Loratadine Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Loratadine Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Loratadine Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Loratadine Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd.
11.1.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Corporation Information
11.1.2 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview
11.1.3 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.1.4 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.1.6 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.1.7 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.1.8 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
11.1.9 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
11.2 Sancai Shiqi Pharmaceutical Co., Ltd.
11.2.1 Sancai Shiqi Pharmaceutical Co., Ltd. Corporation Information
11.2.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
11.2.3 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.2.4 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.2.6 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.2.7 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.2.8 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
11.2.9 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
11.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
11.3.1 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview
11.3.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.3.4 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.3.6 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.3.7 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.3.8 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
11.3.9 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
11.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
11.4.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Corporation Information
11.4.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
11.4.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.4.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.4.6 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.4.7 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.4.8 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
11.4.9 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
11.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
11.5.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Corporation Information
11.5.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
11.5.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.5.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.5.6 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.5.7 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.5.8 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets SWOT Analysis
11.5.9 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
11.6 Jilin Jinheng Pharmaceutical Co., Ltd.
11.6.1 Jilin Jinheng Pharmaceutical Co., Ltd. Corporation Information
11.6.2 Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview
11.6.3 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.6.4 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
11.7 Zhejiang Ruixin Pharmaceutical Co., Ltd.
11.7.1 Zhejiang Ruixin Pharmaceutical Co., Ltd. Corporation Information
11.7.2 Zhejiang Ruixin Pharmaceutical Co., Ltd. Business Overview
11.7.3 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.7.4 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Developments
11.8 Hubei Minkang Pharmaceutical Co., Ltd.
11.8.1 Hubei Minkang Pharmaceutical Co., Ltd. Corporation Information
11.8.2 Hubei Minkang Pharmaceutical Co., Ltd. Business Overview
11.8.3 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.8.4 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
11.9 Anhui Guosen Pharmaceutical Co., Ltd.
11.9.1 Anhui Guosen Pharmaceutical Co., Ltd. Corporation Information
11.9.2 Anhui Guosen Pharmaceutical Co., Ltd. Business Overview
11.9.3 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.9.4 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments
11.10 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
11.10.1 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Corporation Information
11.10.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Business Overview
11.10.3 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.10.4 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments
11.11 Hunan Zhongnan Pharmaceutical Co., Ltd.
11.11.1 Hunan Zhongnan Pharmaceutical Co., Ltd. Corporation Information
11.11.2 Hunan Zhongnan Pharmaceutical Co., Ltd. Business Overview
11.11.3 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.11.4 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments
11.12 Yunpeng Pharmaceutical Group Co., Ltd.
11.12.1 Yunpeng Pharmaceutical Group Co., Ltd. Corporation Information
11.12.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
11.12.3 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.12.4 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
11.13 Tonghua Great Wall Pharmaceutical Co., Ltd.
11.13.1 Tonghua Great Wall Pharmaceutical Co., Ltd. Corporation Information
11.13.2 Tonghua Great Wall Pharmaceutical Co., Ltd. Business Overview
11.13.3 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.13.4 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Developments
11.14 Yunnan Longfa Pharmaceutical Co., Ltd.
11.14.1 Yunnan Longfa Pharmaceutical Co., Ltd. Corporation Information
11.14.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
11.14.3 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.14.4 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
11.15 Shanxi Xinyu Pharmaceutical Co., Ltd.
11.15.1 Shanxi Xinyu Pharmaceutical Co., Ltd. Corporation Information
11.15.2 Shanxi Xinyu Pharmaceutical Co., Ltd. Business Overview
11.15.3 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.15.4 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Developments
11.16 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
11.16.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Corporation Information
11.16.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
11.16.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.16.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
11.17 Guangdong Hengcheng Pharmaceutical Co., Ltd.
11.17.1 Guangdong Hengcheng Pharmaceutical Co., Ltd. Corporation Information
11.17.2 Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview
11.17.3 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.17.4 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
11.18 Sichuan Shenghe Pharmaceutical Co., Ltd.
11.18.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Corporation Information
11.18.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview
11.18.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.18.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
11.19 Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
11.19.1 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Corporation Information
11.19.2 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview
11.19.3 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.19.4 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
11.20 Hunan Erkang Pharmaceutical Co., Ltd.
11.20.1 Hunan Erkang Pharmaceutical Co., Ltd. Corporation Information
11.20.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
11.20.3 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.20.4 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
11.21 Yabao Pharmaceutical Group Co., Ltd.
11.21.1 Yabao Pharmaceutical Group Co., Ltd. Corporation Information
11.21.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
11.21.3 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.21.4 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Loratadine Tablets Industry Chain
12.2 Loratadine Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Loratadine Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Loratadine Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Loratadine Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Loratadine Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Loratadine Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Loratadine Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 20 mg/Tablet
1.2.3 40 mg/Tablet
1.2.4 60 mg/Tablet
1.3 Market Segmentation by Application
1.3.1 Global Loratadine Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Online e-commerce
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Loratadine Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Loratadine Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Loratadine Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Loratadine Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Loratadine Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Loratadine Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 20 mg/Tablet Market Size by Manufacturers
3.5.2 40 mg/Tablet Market Size by Manufacturers
3.5.3 60 mg/Tablet Market Size by Manufacturers
3.6 Global Loratadine Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Loratadine Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Loratadine Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Loratadine Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Loratadine Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Loratadine Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Loratadine Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Loratadine Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Loratadine Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Loratadine Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Loratadine Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Loratadine Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Loratadine Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Loratadine Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Loratadine Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Loratadine Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Loratadine Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Loratadine Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Loratadine Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Loratadine Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd.
11.1.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Corporation Information
11.1.2 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview
11.1.3 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.1.4 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.1.6 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.1.7 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.1.8 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
11.1.9 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
11.2 Sancai Shiqi Pharmaceutical Co., Ltd.
11.2.1 Sancai Shiqi Pharmaceutical Co., Ltd. Corporation Information
11.2.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
11.2.3 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.2.4 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.2.6 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.2.7 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.2.8 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
11.2.9 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
11.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
11.3.1 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview
11.3.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.3.4 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.3.6 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.3.7 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.3.8 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
11.3.9 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
11.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
11.4.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Corporation Information
11.4.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
11.4.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.4.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.4.6 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.4.7 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.4.8 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
11.4.9 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
11.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
11.5.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Corporation Information
11.5.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
11.5.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.5.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales by Product in 2024
11.5.6 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales by Application in 2024
11.5.7 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales by Geographic Area in 2024
11.5.8 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets SWOT Analysis
11.5.9 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
11.6 Jilin Jinheng Pharmaceutical Co., Ltd.
11.6.1 Jilin Jinheng Pharmaceutical Co., Ltd. Corporation Information
11.6.2 Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview
11.6.3 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.6.4 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
11.7 Zhejiang Ruixin Pharmaceutical Co., Ltd.
11.7.1 Zhejiang Ruixin Pharmaceutical Co., Ltd. Corporation Information
11.7.2 Zhejiang Ruixin Pharmaceutical Co., Ltd. Business Overview
11.7.3 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.7.4 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Developments
11.8 Hubei Minkang Pharmaceutical Co., Ltd.
11.8.1 Hubei Minkang Pharmaceutical Co., Ltd. Corporation Information
11.8.2 Hubei Minkang Pharmaceutical Co., Ltd. Business Overview
11.8.3 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.8.4 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
11.9 Anhui Guosen Pharmaceutical Co., Ltd.
11.9.1 Anhui Guosen Pharmaceutical Co., Ltd. Corporation Information
11.9.2 Anhui Guosen Pharmaceutical Co., Ltd. Business Overview
11.9.3 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.9.4 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments
11.10 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
11.10.1 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Corporation Information
11.10.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Business Overview
11.10.3 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.10.4 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments
11.11 Hunan Zhongnan Pharmaceutical Co., Ltd.
11.11.1 Hunan Zhongnan Pharmaceutical Co., Ltd. Corporation Information
11.11.2 Hunan Zhongnan Pharmaceutical Co., Ltd. Business Overview
11.11.3 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.11.4 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments
11.12 Yunpeng Pharmaceutical Group Co., Ltd.
11.12.1 Yunpeng Pharmaceutical Group Co., Ltd. Corporation Information
11.12.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
11.12.3 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.12.4 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
11.13 Tonghua Great Wall Pharmaceutical Co., Ltd.
11.13.1 Tonghua Great Wall Pharmaceutical Co., Ltd. Corporation Information
11.13.2 Tonghua Great Wall Pharmaceutical Co., Ltd. Business Overview
11.13.3 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.13.4 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Developments
11.14 Yunnan Longfa Pharmaceutical Co., Ltd.
11.14.1 Yunnan Longfa Pharmaceutical Co., Ltd. Corporation Information
11.14.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
11.14.3 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.14.4 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
11.15 Shanxi Xinyu Pharmaceutical Co., Ltd.
11.15.1 Shanxi Xinyu Pharmaceutical Co., Ltd. Corporation Information
11.15.2 Shanxi Xinyu Pharmaceutical Co., Ltd. Business Overview
11.15.3 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.15.4 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Developments
11.16 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
11.16.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Corporation Information
11.16.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
11.16.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.16.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
11.17 Guangdong Hengcheng Pharmaceutical Co., Ltd.
11.17.1 Guangdong Hengcheng Pharmaceutical Co., Ltd. Corporation Information
11.17.2 Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview
11.17.3 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.17.4 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
11.18 Sichuan Shenghe Pharmaceutical Co., Ltd.
11.18.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Corporation Information
11.18.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview
11.18.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.18.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
11.19 Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
11.19.1 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Corporation Information
11.19.2 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview
11.19.3 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.19.4 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
11.20 Hunan Erkang Pharmaceutical Co., Ltd.
11.20.1 Hunan Erkang Pharmaceutical Co., Ltd. Corporation Information
11.20.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
11.20.3 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.20.4 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
11.21 Yabao Pharmaceutical Group Co., Ltd.
11.21.1 Yabao Pharmaceutical Group Co., Ltd. Corporation Information
11.21.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
11.21.3 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Models, Descriptions and Specifications
11.21.4 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Loratadine Tablets Industry Chain
12.2 Loratadine Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Loratadine Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Loratadine Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Loratadine Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Loratadine Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Loratadine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Loratadine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Loratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Loratadine Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Loratadine Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Loratadine Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Loratadine Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Loratadine Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Loratadine Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Loratadine Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Loratadine Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Loratadine Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Loratadine Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Loratadine Tablets as of 2024)
Table 16. Global Loratadine Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Loratadine Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Loratadine Tablets Manufacturing Base and Headquarters
Table 19. Global Loratadine Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Loratadine Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Loratadine Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Loratadine Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Loratadine Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Loratadine Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Loratadine Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Loratadine Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Loratadine Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Loratadine Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Loratadine Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Loratadine Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Loratadine Tablets Growth Accelerators and Market Barriers
Table 37. North America Loratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Loratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Loratadine Tablets Growth Accelerators and Market Barriers
Table 40. Europe Loratadine Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Loratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Loratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Loratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Loratadine Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Loratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Loratadine Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Loratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Loratadine Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Loratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Corporation Information
Table 51. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Description and Major Businesses
Table 52. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 53. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 55. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 56. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 57. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
Table 58. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
Table 59. Sancai Shiqi Pharmaceutical Co., Ltd. Corporation Information
Table 60. Sancai Shiqi Pharmaceutical Co., Ltd. Description and Major Businesses
Table 61. Sancai Shiqi Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 62. Sancai Shiqi Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Sancai Shiqi Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 64. Sancai Shiqi Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 65. Sancai Shiqi Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 66. Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
Table 67. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
Table 68. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Corporation Information
Table 69. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Description and Major Businesses
Table 70. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 71. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 73. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 74. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 75. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
Table 76. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
Table 77. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Corporation Information
Table 78. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Description and Major Businesses
Table 79. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 80. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 82. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 83. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 84. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
Table 85. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
Table 86. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Corporation Information
Table 87. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 88. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 89. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Sales Value Proportion by Product in 2024
Table 91. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Sales Value Proportion by Application in 2024
Table 92. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 93. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets SWOT Analysis
Table 94. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
Table 95. Jilin Jinheng Pharmaceutical Co., Ltd. Corporation Information
Table 96. Jilin Jinheng Pharmaceutical Co., Ltd. Description and Major Businesses
Table 97. Jilin Jinheng Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 98. Jilin Jinheng Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
Table 100. Zhejiang Ruixin Pharmaceutical Co., Ltd. Corporation Information
Table 101. Zhejiang Ruixin Pharmaceutical Co., Ltd. Description and Major Businesses
Table 102. Zhejiang Ruixin Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 103. Zhejiang Ruixin Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Developments
Table 105. Hubei Minkang Pharmaceutical Co., Ltd. Corporation Information
Table 106. Hubei Minkang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 107. Hubei Minkang Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 108. Hubei Minkang Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
Table 110. Anhui Guosen Pharmaceutical Co., Ltd. Corporation Information
Table 111. Anhui Guosen Pharmaceutical Co., Ltd. Description and Major Businesses
Table 112. Anhui Guosen Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 113. Anhui Guosen Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments
Table 115. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Corporation Information
Table 116. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Description and Major Businesses
Table 117. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 118. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments
Table 120. Hunan Zhongnan Pharmaceutical Co., Ltd. Corporation Information
Table 121. Hunan Zhongnan Pharmaceutical Co., Ltd. Description and Major Businesses
Table 122. Hunan Zhongnan Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 123. Hunan Zhongnan Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments
Table 125. Yunpeng Pharmaceutical Group Co., Ltd. Corporation Information
Table 126. Yunpeng Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 127. Yunpeng Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 128. Yunpeng Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
Table 130. Tonghua Great Wall Pharmaceutical Co., Ltd. Corporation Information
Table 131. Tonghua Great Wall Pharmaceutical Co., Ltd. Description and Major Businesses
Table 132. Tonghua Great Wall Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 133. Tonghua Great Wall Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Developments
Table 135. Yunnan Longfa Pharmaceutical Co., Ltd. Corporation Information
Table 136. Yunnan Longfa Pharmaceutical Co., Ltd. Description and Major Businesses
Table 137. Yunnan Longfa Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 138. Yunnan Longfa Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
Table 140. Shanxi Xinyu Pharmaceutical Co., Ltd. Corporation Information
Table 141. Shanxi Xinyu Pharmaceutical Co., Ltd. Description and Major Businesses
Table 142. Shanxi Xinyu Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 143. Shanxi Xinyu Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Developments
Table 145. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Corporation Information
Table 146. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 147. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 148. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
Table 150. Guangdong Hengcheng Pharmaceutical Co., Ltd. Corporation Information
Table 151. Guangdong Hengcheng Pharmaceutical Co., Ltd. Description and Major Businesses
Table 152. Guangdong Hengcheng Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 153. Guangdong Hengcheng Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
Table 155. Sichuan Shenghe Pharmaceutical Co., Ltd. Corporation Information
Table 156. Sichuan Shenghe Pharmaceutical Co., Ltd. Description and Major Businesses
Table 157. Sichuan Shenghe Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 158. Sichuan Shenghe Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
Table 160. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Corporation Information
Table 161. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 162. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 163. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
Table 165. Hunan Erkang Pharmaceutical Co., Ltd. Corporation Information
Table 166. Hunan Erkang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 167. Hunan Erkang Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 168. Hunan Erkang Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
Table 170. Yabao Pharmaceutical Group Co., Ltd. Corporation Information
Table 171. Yabao Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 172. Yabao Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 173. Yabao Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Yabao Pharmaceutical Group Co., Ltd. Recent Developments
Table 175. Key Raw Materials Distribution
Table 176. Raw Materials Key Suppliers
Table 177. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 178. Milestones in Production Technology Evolution
Table 179. Distributors List
Table 180. Market Trends and Market Evolution
Table 181. Market Drivers and Opportunities
Table 182. Market Challenges, Risks, and Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Loratadine Tablets Product Picture
Figure 2. Global Loratadine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 20 mg/Tablet Product Picture
Figure 4. 40 mg/Tablet Product Picture
Figure 5. 60 mg/Tablet Product Picture
Figure 6. Global Loratadine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Online e-commerce
Figure 10. Other
Figure 11. Loratadine Tablets Report Years Considered
Figure 12. Global Loratadine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 14. Global Loratadine Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Loratadine Tablets Revenue Market Share by Region (2020-2031)
Figure 16. Global Loratadine Tablets Sales (2020-2031) & (K Units)
Figure 17. Global Loratadine Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Loratadine Tablets Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Loratadine Tablets Sales Volume Market Share in 2024
Figure 20. Global Loratadine Tablets Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. 20 mg/Tablet Revenue Market Share by Manufacturer in 2024
Figure 23. 40 mg/Tablet Revenue Market Share by Manufacturer in 2024
Figure 24. 60 mg/Tablet Revenue Market Share by Manufacturer in 2024
Figure 25. Global Loratadine Tablets Sales Market Share by Type (2020-2031)
Figure 26. Global Loratadine Tablets Revenue Market Share by Type (2020-2031)
Figure 27. Global Loratadine Tablets Sales Market Share by Application (2020-2031)
Figure 28. Global Loratadine Tablets Revenue Market Share by Application (2020-2031)
Figure 29. North America Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 30. North America Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 32. North America Loratadine Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 33. North America Loratadine Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 35. North America Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 40. Europe Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 42. Europe Loratadine Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 43. Europe Loratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 45. Europe Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 47. France Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 52. Asia-Pacific Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Loratadine Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 55. Asia-Pacific Loratadine Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 57. Asia-Pacific Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 62. India Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 64. Central and South America Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Loratadine Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 67. Central and South America Loratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 69. Central and South America Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 73. Middle East and Africa Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Loratadine Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 76. South America Loratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 78. Middle East and Africa Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 83. Loratadine Tablets Industry Chain Mapping
Figure 84. Regional Loratadine Tablets Manufacturing Base Distribution (%)
Figure 85. Global Loratadine Tablets Production Market Share by Region (2020-2031)
Figure 86. Loratadine Tablets Production Process
Figure 87. Regional Loratadine Tablets Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Table 1. Global Loratadine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Loratadine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Loratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Loratadine Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Loratadine Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Loratadine Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Loratadine Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Loratadine Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Loratadine Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Loratadine Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Loratadine Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Loratadine Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Loratadine Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Loratadine Tablets as of 2024)
Table 16. Global Loratadine Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Loratadine Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Loratadine Tablets Manufacturing Base and Headquarters
Table 19. Global Loratadine Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Loratadine Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Loratadine Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Loratadine Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Loratadine Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Loratadine Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Loratadine Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Loratadine Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Loratadine Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Loratadine Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Loratadine Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Loratadine Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Loratadine Tablets Growth Accelerators and Market Barriers
Table 37. North America Loratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Loratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Loratadine Tablets Growth Accelerators and Market Barriers
Table 40. Europe Loratadine Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Loratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Loratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Loratadine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Loratadine Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Loratadine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Loratadine Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Loratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Loratadine Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Loratadine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Corporation Information
Table 51. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Description and Major Businesses
Table 52. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 53. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 55. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 56. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 57. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
Table 58. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
Table 59. Sancai Shiqi Pharmaceutical Co., Ltd. Corporation Information
Table 60. Sancai Shiqi Pharmaceutical Co., Ltd. Description and Major Businesses
Table 61. Sancai Shiqi Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 62. Sancai Shiqi Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Sancai Shiqi Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 64. Sancai Shiqi Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 65. Sancai Shiqi Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 66. Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
Table 67. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
Table 68. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Corporation Information
Table 69. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Description and Major Businesses
Table 70. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 71. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 73. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 74. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 75. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
Table 76. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
Table 77. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Corporation Information
Table 78. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Description and Major Businesses
Table 79. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 80. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 82. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 83. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 84. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets SWOT Analysis
Table 85. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
Table 86. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Corporation Information
Table 87. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 88. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 89. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Sales Value Proportion by Product in 2024
Table 91. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Sales Value Proportion by Application in 2024
Table 92. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 93. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets SWOT Analysis
Table 94. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
Table 95. Jilin Jinheng Pharmaceutical Co., Ltd. Corporation Information
Table 96. Jilin Jinheng Pharmaceutical Co., Ltd. Description and Major Businesses
Table 97. Jilin Jinheng Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 98. Jilin Jinheng Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
Table 100. Zhejiang Ruixin Pharmaceutical Co., Ltd. Corporation Information
Table 101. Zhejiang Ruixin Pharmaceutical Co., Ltd. Description and Major Businesses
Table 102. Zhejiang Ruixin Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 103. Zhejiang Ruixin Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Developments
Table 105. Hubei Minkang Pharmaceutical Co., Ltd. Corporation Information
Table 106. Hubei Minkang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 107. Hubei Minkang Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 108. Hubei Minkang Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
Table 110. Anhui Guosen Pharmaceutical Co., Ltd. Corporation Information
Table 111. Anhui Guosen Pharmaceutical Co., Ltd. Description and Major Businesses
Table 112. Anhui Guosen Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 113. Anhui Guosen Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments
Table 115. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Corporation Information
Table 116. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Description and Major Businesses
Table 117. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 118. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments
Table 120. Hunan Zhongnan Pharmaceutical Co., Ltd. Corporation Information
Table 121. Hunan Zhongnan Pharmaceutical Co., Ltd. Description and Major Businesses
Table 122. Hunan Zhongnan Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 123. Hunan Zhongnan Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments
Table 125. Yunpeng Pharmaceutical Group Co., Ltd. Corporation Information
Table 126. Yunpeng Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 127. Yunpeng Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 128. Yunpeng Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
Table 130. Tonghua Great Wall Pharmaceutical Co., Ltd. Corporation Information
Table 131. Tonghua Great Wall Pharmaceutical Co., Ltd. Description and Major Businesses
Table 132. Tonghua Great Wall Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 133. Tonghua Great Wall Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Developments
Table 135. Yunnan Longfa Pharmaceutical Co., Ltd. Corporation Information
Table 136. Yunnan Longfa Pharmaceutical Co., Ltd. Description and Major Businesses
Table 137. Yunnan Longfa Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 138. Yunnan Longfa Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
Table 140. Shanxi Xinyu Pharmaceutical Co., Ltd. Corporation Information
Table 141. Shanxi Xinyu Pharmaceutical Co., Ltd. Description and Major Businesses
Table 142. Shanxi Xinyu Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 143. Shanxi Xinyu Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Developments
Table 145. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Corporation Information
Table 146. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 147. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 148. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
Table 150. Guangdong Hengcheng Pharmaceutical Co., Ltd. Corporation Information
Table 151. Guangdong Hengcheng Pharmaceutical Co., Ltd. Description and Major Businesses
Table 152. Guangdong Hengcheng Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 153. Guangdong Hengcheng Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
Table 155. Sichuan Shenghe Pharmaceutical Co., Ltd. Corporation Information
Table 156. Sichuan Shenghe Pharmaceutical Co., Ltd. Description and Major Businesses
Table 157. Sichuan Shenghe Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 158. Sichuan Shenghe Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
Table 160. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Corporation Information
Table 161. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 162. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 163. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
Table 165. Hunan Erkang Pharmaceutical Co., Ltd. Corporation Information
Table 166. Hunan Erkang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 167. Hunan Erkang Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 168. Hunan Erkang Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
Table 170. Yabao Pharmaceutical Group Co., Ltd. Corporation Information
Table 171. Yabao Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 172. Yabao Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
Table 173. Yabao Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Yabao Pharmaceutical Group Co., Ltd. Recent Developments
Table 175. Key Raw Materials Distribution
Table 176. Raw Materials Key Suppliers
Table 177. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 178. Milestones in Production Technology Evolution
Table 179. Distributors List
Table 180. Market Trends and Market Evolution
Table 181. Market Drivers and Opportunities
Table 182. Market Challenges, Risks, and Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Loratadine Tablets Product Picture
Figure 2. Global Loratadine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 20 mg/Tablet Product Picture
Figure 4. 40 mg/Tablet Product Picture
Figure 5. 60 mg/Tablet Product Picture
Figure 6. Global Loratadine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Online e-commerce
Figure 10. Other
Figure 11. Loratadine Tablets Report Years Considered
Figure 12. Global Loratadine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 14. Global Loratadine Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Loratadine Tablets Revenue Market Share by Region (2020-2031)
Figure 16. Global Loratadine Tablets Sales (2020-2031) & (K Units)
Figure 17. Global Loratadine Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Loratadine Tablets Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Loratadine Tablets Sales Volume Market Share in 2024
Figure 20. Global Loratadine Tablets Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. 20 mg/Tablet Revenue Market Share by Manufacturer in 2024
Figure 23. 40 mg/Tablet Revenue Market Share by Manufacturer in 2024
Figure 24. 60 mg/Tablet Revenue Market Share by Manufacturer in 2024
Figure 25. Global Loratadine Tablets Sales Market Share by Type (2020-2031)
Figure 26. Global Loratadine Tablets Revenue Market Share by Type (2020-2031)
Figure 27. Global Loratadine Tablets Sales Market Share by Application (2020-2031)
Figure 28. Global Loratadine Tablets Revenue Market Share by Application (2020-2031)
Figure 29. North America Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 30. North America Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 32. North America Loratadine Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 33. North America Loratadine Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 35. North America Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 40. Europe Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 42. Europe Loratadine Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 43. Europe Loratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 45. Europe Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 47. France Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 52. Asia-Pacific Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Loratadine Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 55. Asia-Pacific Loratadine Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 57. Asia-Pacific Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 62. India Loratadine Tablets Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 64. Central and South America Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Loratadine Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 67. Central and South America Loratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 69. Central and South America Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Loratadine Tablets Sales YoY (2020-2031) & (K Units)
Figure 73. Middle East and Africa Loratadine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Loratadine Tablets Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Loratadine Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 76. South America Loratadine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Loratadine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 78. Middle East and Africa Loratadine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Loratadine Tablets Revenue (2020-2025) & (US$ Million)
Figure 83. Loratadine Tablets Industry Chain Mapping
Figure 84. Regional Loratadine Tablets Manufacturing Base Distribution (%)
Figure 85. Global Loratadine Tablets Production Market Share by Region (2020-2031)
Figure 86. Loratadine Tablets Production Process
Figure 87. Regional Loratadine Tablets Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232